U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $97.50 Average Price Target from Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $97.50.

USPH has been the subject of a number of analyst reports. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Thursday, March 12th. Citizens Jmp reaffirmed a “market outperform” rating and set a $98.00 target price on shares of U.S. Physical Therapy in a research note on Wednesday. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Finally, Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, June 8th. The stock was bought at an average price of $63.14 per share, with a total value of $31,064.88. Following the completion of the transaction, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently made changes to their positions in USPH. Royal Bank of Canada increased its position in shares of U.S. Physical Therapy by 3.4% during the first quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock valued at $5,733,000 after acquiring an additional 2,594 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in U.S. Physical Therapy by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after purchasing an additional 391 shares during the last quarter. Jane Street Group LLC boosted its holdings in U.S. Physical Therapy by 249.3% in the first quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after purchasing an additional 35,191 shares during the last quarter. Hsbc Holdings PLC purchased a new stake in U.S. Physical Therapy in the second quarter worth approximately $410,000. Finally, First Trust Advisors LP boosted its holdings in U.S. Physical Therapy by 3.7% in the second quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock worth $839,000 after purchasing an additional 385 shares during the last quarter.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $66.45 on Friday. U.S. Physical Therapy has a fifty-two week low of $58.19 and a fifty-two week high of $93.50. The company has a 50 day simple moving average of $66.18 and a two-hundred day simple moving average of $75.66. The company has a market capitalization of $1.01 billion, a price-to-earnings ratio of 132.90, a P/E/G ratio of 1.83 and a beta of 1.16. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The business had revenue of $198.29 million for the quarter, compared to the consensus estimate of $200.94 million. During the same period in the prior year, the business posted $0.48 EPS. U.S. Physical Therapy’s revenue for the quarter was up 7.9% on a year-over-year basis. Analysts expect that U.S. Physical Therapy will post 2.99 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 22nd were given a dividend of $0.46 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.84 annualized dividend and a dividend yield of 2.8%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 368.00%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.